News Briefs: Teleflex Acquires Vidacare; Integra Buys Covidien’s DuraSeal Line
This article was originally published in The Gray Sheet
Executive Summary
Teleflex buys Vidacare Corp. for $262.5 million. Integra LifeSciences acquires Covidien’s Confluent Surgical product line, including the DuraSeal products, for $235 million, plus up to $30 million in milestone payments. W.L. Gore ordered to pay more than $850 million to C.R. Bard to partially resolve a long-running patent dispute. More news.
You may also be interested in...
Nightly Home Hemodialysis Gains First FDA Clearance
NxStage’s System One has received an expanded indication to treat patients overnight at home, which the company says improves quality of life.
NxStage Dialysis Needle Technology Gets FDA Nod
The company says its new needle technology means patients will only need to be pricked once during a dialysis procedure instead of twice which will reduce their discomfort while preserving vascular access.
Regulatory Briefs: FDA Meetings On Cancer Tests, Glaucoma Devices; DeLauro Questions Device Reclassifications
An FDA advisory panel will discuss PMAs for two molecular diagnostics for colorectal cancer screening in March. A February workshop will address clinical trial design for minimally invasive glaucoma devices. Rep. DeLauro speaks out about FDA device reclassifications. More regulatory briefs.